Poplar Point Capital Management LLC 13D and 13G filings for NovaBay Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-04 12:46 pm Purchase |
2025-06-03 | 13D | NovaBay Pharmaceuticals, Inc. NBY |
Poplar Point Capital Management LLC | 1,020,300 17.540% |
48,646 (+5.01%) |
Filing |
| 2025-05-15 09:00 am Purchase |
2025-03-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY |
Poplar Point Capital Management LLC | 971,654 16.710% |
350,969 (+56.55%) |
Filing |
| 2025-02-06 6:30 pm Purchase |
2025-01-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY |
Poplar Point Capital Management LLC | 620,685 12.700% |
242,388 (+64.07%) |
Filing |
| 2025-01-10 6:06 pm Purchase |
2024-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY |
Poplar Point Capital Management LLC | 378,297 7.700% |
378,297 (New Position) |
Filing |